Ardent Health Partners, Inc.(ARDT)
$18.19+0.26 (+1.45%)
ARDT
Ardent Health Partners, Inc. stock forecast
$18.19
At close:+0.26 (+1.45%)
Want to see ARDT full AI Analyst Report?
Ardent Health Partners, Inc. (ARDT) Stock Forecast & Price Target
106 Followers
ARDT Analyst Ratings
Moderate Buy
6Buy2Hold1Sell
Based on 9 analysts giving stock ratings to Ardent Health Partners, Inc. in the past 3 months
ARDT Stock 12 Month Forecast
Average Price Target
$18.25â–˛(0.33% Upside)Based on 9 Wall Street analysts offering 12 month price targets for Ardent Health Partners, Inc. in the last 3 months. The average price target is $18.25 with a high forecast of $21.00 and a low forecast of $13.50. The average price target represents a 0.33% change from the last price of $18.19.
Past 12 Months12 Month ForecastJan2026Oct2026
High$21.00
Average$18.25
Low$13.50
Highest Price TargetHighest$21.00Average Price Target$18.25Lowest Price TargetLowest$13.50
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ann Hynes | Mizuho Securities | $13→$21 | buy | 15.45%Upside | Reiterated | 11/11/26 | ||
| A.J. Rice | UBS | $13.50→$20 | buy | 9.95%Upside | Assigned | 11/09/26 | ||
 Unknown AnalystNot Ranked | Stephens | $21 | buy | 15.45%Upside | Assigned | 11/06/26 | ||
| Ben Hendrix | RBC Capital | $13→$18 | buy | -1.04%Downside | Reiterated | 11/06/26 | ||
| Craig Hettenbach | Morgan Stanley | $12→$13.50 | hold | -25.78%Downside | Assigned | 11/06/26 | ||
| Kevin Fischbeck | Bank of America Securities | ― | sell | ― | Reiterated | 11/05/26 | ||
| Sean Dodge | BMO Capital | $11→$16 | hold | -12.04%Downside | Assigned | 11/05/26 | ||
| David S Macdonald | Truist Financial | ― | buy | ― | Reiterated | 09/30/26 | ||
| Whit Mayo | Leerink Partners | ― | buy | ― | Reiterated | 09/17/26 | ||
| Scott Fidel | Goldman Sachs | $11→$13 | hold | -28.53%Downside | Reiterated | 08/10/26 | ||
| Jason Cassorla | Guggenheim | $13→$14 | buy | -23.03%Downside | Reiterated | 08/05/26 | ||
| Matthew Gillmor CFA | KeyBanc | ― | hold | ― | Reiterated | 06/03/26 | ||
| Benjamin Rossi | J.P. Morgan | $15→$12 | hold | -34.03%Downside | Reiterated | 11/24/25 | ||
| Timothy Greaves | Loop Capital Markets | $17 | buy | -6.54%Downside | Reiterated | 11/14/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ann HynesMizuho Securities | BuyReiterated$13→$21 | 11/11/26 | 15.45%Upside | ||
| A.J. RiceUBS | BuyAssigned$13.50→$20 | 11/09/26 | 9.95%Upside | ||
| Unknown AnalystStephensNot Ranked | BuyAssigned$21 | 11/06/26 | 15.45%Upside | ||
| Ben HendrixRBC Capital | BuyReiterated$13→$18 | 11/06/26 | -1.04%Downside | ||
| Craig HettenbachMorgan Stanley | HoldAssigned$12→$13.50 | 11/06/26 | -25.78%Downside | ||
| Kevin FischbeckBank of America Securities | SellReiterated | 11/05/26 | ― | ||
| Sean DodgeBMO Capital | HoldAssigned$11→$16 | 11/05/26 | -12.04%Downside | ||
| David S MacdonaldTruist Financial | BuyReiterated | 09/30/26 | ― | ||
| Whit MayoLeerink Partners | BuyReiterated | 09/17/26 | ― | ||
| Scott FidelGoldman Sachs | HoldReiterated$11→$13 | 08/10/26 | -28.53%Downside | ||
| Jason CassorlaGuggenheim | BuyReiterated$13→$14 | 08/05/26 | -23.03%Downside | ||
| Matthew Gillmor CFAKeyBanc | HoldReiterated | 06/03/26 | ― | ||
| Benjamin RossiJ.P. Morgan | HoldReiterated$15→$12 | 11/24/25 | -34.03%Downside | ||
| Timothy GreavesLoop Capital Markets | BuyReiterated$17 | 11/14/25 | -6.54%Downside |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Ardent Health Partners, Inc.
3 Months
Success Rate9/10 ratings generated profit
90%
Average Return
+19.51%
Copying Jason Cassorla's trades and holding each position for 3 Months would result in 90.00% of your transactions generating a profit, with an average return of +19.51% per trade.
1 Year
Success Rate7/10 ratings generated profit
70%
Average Return
+49.09%
Copying Jason Cassorla's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +49.09% per trade.
2 Years
Success Rate10/10 ratings generated profit
100%
Average Return
+72.02%
Copying Jason Cassorla's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +72.02% per trade.
ARDT Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 0 | 0 | 0 |
| Buy | 8 | 7 | 8 | 7 | 7 |
| Hold | 7 | 8 | 4 | 4 | 3 |
| Sell | 3 | 5 | 4 | 2 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 20 | 22 | 16 | 13 | 11 |
In the current month, ARDT has received 7 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. ARDT average Analyst price target in the past 3 months is 18.25.
ARDT Financial Forecast
High$0.43
Consensus$0.35
Low$0.29
ARDT Earnings Forecast
Next quarter’s earnings estimate for ARDT is $0.35 with a range of $0.29 to $0.43. The previous quarter’s EPS was $0.31. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
High$1.66B
Consensus$1.64B
Low$1.61B
ARDT Sales Forecast
Next quarter’s sales forecast for ARDT is $1.64B with a range of $1.61B to $1.66B. The previous quarter’s sales results were $1.62B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
ARDT Stock Forecast FAQ
What is ARDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Ardent Health Partners, Inc.’s 12-month average price target is $18.25.
What is ARDT’s upside potential, based on the analysts’ average price target?
Ardent Health Partners, Inc. has 0.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ARDT a Buy, Sell or Hold?
Ardent Health Partners, Inc. has a consensus rating of Moderate Buy which is based on 6 buy ratings, 2 hold ratings and 1 sell ratings.
What is Ardent Health Partners, Inc.’s price target?
The average price target for Ardent Health Partners, Inc. is $18.25. This is based on 9 12-month price targets, issued in the past 3 months. The highest analyst price target is $21.00, the lowest forecast is $13.50. The average price target represents a 0.33% increase from the current price of $18.19.
What do analysts say about Ardent Health Partners, Inc.?
Ardent Health Partners, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Street analysts.
How can I buy shares of ARDT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
